Evren Technologies has developed a groundbreaking therapy called Phoenix® specifically designed for the treatment of Post-traumatic Stress Disorder (PTSD).
The Phoenix® therapy involves using earbud devices that deliver a gentle electrical stimulation to activate the vagus nerve, inducing a calming effect on the body and helping to alleviate the symptoms of PTSD.
With its discreet earbud design, the Phoenix® device enables transcutaneous auricular vagal nerve stimulation (taVNS) to be delivered effectively.
By incorporating transcutaneous auricular vagal nerve stimulation (taVNS) in a closed-loop system, the Phoenix earbud device offers personalized medicine that addresses the underlying autonomic imbalance associated with PTSD.
Recognizing its revolutionary potential, the Phoenix® therapy has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Post-traumatic Stress Disorder (PTSD).
PTSD affects a significant number of individuals, with approximately 7.5 million Americans seeking treatment for this condition annually. Furthermore, the rates of PTSD have significantly increased as a result of the COVID-19 pandemic.
